231 related articles for article (PubMed ID: 35093393)
1. Targeting lipophagy as a potential therapeutic strategy for nonalcoholic fatty liver disease.
Li HY; Peng ZG
Biochem Pharmacol; 2022 Mar; 197():114933. PubMed ID: 35093393
[TBL] [Abstract][Full Text] [Related]
2. Lipophagy: A potential therapeutic target for nonalcoholic and alcoholic fatty liver disease.
Han YH; He XM; Jin MH; Sun HN; Kwon T
Biochem Biophys Res Commun; 2023 Sep; 672():36-44. PubMed ID: 37336123
[TBL] [Abstract][Full Text] [Related]
3. Lipotoxicity-induced STING1 activation stimulates MTORC1 and restricts hepatic lipophagy.
Liu K; Qiu D; Liang X; Huang Y; Wang Y; Jia X; Li K; Zhao J; Du C; Qiu X; Cui J; Xiao Z; Qin Y; Zhang Q
Autophagy; 2022 Apr; 18(4):860-876. PubMed ID: 34382907
[TBL] [Abstract][Full Text] [Related]
4. Exercise against nonalcoholic fatty liver disease: Possible role and mechanism of lipophagy.
Su P; Chen JG; Tang DH
Life Sci; 2023 Aug; 327():121837. PubMed ID: 37301321
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitination of cytoplasmic HMGB1 by RNF186 regulates hepatic lipophagy in non-alcoholic fatty liver disease.
Du J; Ji X; Xu B; Du Q; Li Y; Zhou B; Liu X; Xu Z; Jiang Y; Kou B; Li Z; Cui C; Lin J
Metabolism; 2024 Mar; 152():155769. PubMed ID: 38158076
[TBL] [Abstract][Full Text] [Related]
6. Water Extract of Dolichos lablab Attenuates Hepatic Lipid Accumulation in a Cellular Nonalcoholic Fatty Liver Disease Model.
Im AR; Kim YH; Lee HW; Song KH
J Med Food; 2016 May; 19(5):495-503. PubMed ID: 27152979
[TBL] [Abstract][Full Text] [Related]
7. ω-3 Fatty acids reverse lipotoxity through induction of autophagy in nonalcoholic fatty liver disease.
Chen Y; Xu C; Yan T; Yu C; Li Y
Nutrition; 2015; 31(11-12):1423-1429.e2. PubMed ID: 26429665
[TBL] [Abstract][Full Text] [Related]
8. Exercise and dietary intervention ameliorate high-fat diet-induced NAFLD and liver aging by inducing lipophagy.
Gao Y; Zhang W; Zeng LQ; Bai H; Li J; Zhou J; Zhou GY; Fang CW; Wang F; Qin XJ
Redox Biol; 2020 Sep; 36():101635. PubMed ID: 32863214
[TBL] [Abstract][Full Text] [Related]
9. Traditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver disease.
Liu C; Liao JZ; Li PY
World J Gastroenterol; 2017 Mar; 23(11):1964-1973. PubMed ID: 28373762
[TBL] [Abstract][Full Text] [Related]
10. An overview of deregulated lipid metabolism in nonalcoholic fatty liver disease with special focus on lysosomal acid lipase.
Carotti S; Aquilano K; Valentini F; Ruggiero S; Alletto F; Morini S; Picardi A; Antonelli-Incalzi R; Lettieri-Barbato D; Vespasiani-Gentilucci U
Am J Physiol Gastrointest Liver Physiol; 2020 Oct; 319(4):G469-G480. PubMed ID: 32812776
[TBL] [Abstract][Full Text] [Related]
11. Research Progress on Lipophagy-Mediated Exercise Intervention in Non-Alcoholic Fatty Liver Disease.
Li X; Yang Y; Sun Y; Ding S
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542126
[TBL] [Abstract][Full Text] [Related]
12. Alterations of Lipid Profile in Livers with Impaired Lipophagy.
Jonas W; Schwerbel K; Zellner L; Jähnert M; Gottmann P; Schürmann A
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233162
[TBL] [Abstract][Full Text] [Related]
13. Emerging role of lipophagy in liver disorders.
Nazeer B; Khawar MB; Khalid MU; Hamid SE; Rafiq M; Abbasi MH; Sheikh N; Ali A; Fatima H; Ahmad S
Mol Cell Biochem; 2024 Jan; 479(1):1-11. PubMed ID: 36943663
[TBL] [Abstract][Full Text] [Related]
14. Formononetin alleviates hepatic steatosis by facilitating TFEB-mediated lysosome biogenesis and lipophagy.
Wang Y; Zhao H; Li X; Wang Q; Yan M; Zhang H; Zhao T; Zhang N; Zhang P; Peng L; Li P
J Nutr Biochem; 2019 Nov; 73():108214. PubMed ID: 31520816
[TBL] [Abstract][Full Text] [Related]
15. Naringin Protects against Non-Alcoholic Fatty Liver Disease by Promoting Autophagic Flux and Lipophagy.
Guan L; Guo L; Zhang H; Liu H; Zhou W; Zhai Y; Yan X; Men X; Peng L
Mol Nutr Food Res; 2024 Feb; 68(3):e2200812. PubMed ID: 38054638
[TBL] [Abstract][Full Text] [Related]
16. The essential effect of mTORC1-dependent lipophagy in non-alcoholic fatty liver disease.
Tan X; Huang X; Lu Z; Chen L; Hu J; Tian X; Qiu Z
Front Pharmacol; 2023; 14():1124003. PubMed ID: 36969837
[TBL] [Abstract][Full Text] [Related]
17. Involvement of Lipophagy and Chaperone-Mediated Autophagy in the Pathogenesis of Non-Alcoholic Fatty Liver Disease by Regulation of Lipid Droplets.
Mastoridou EM; Goussia AC; Kanavaros P; Charchanti AV
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958873
[TBL] [Abstract][Full Text] [Related]
18. Liver lipophagy ameliorates nonalcoholic steatohepatitis through extracellular lipid secretion.
Minami Y; Hoshino A; Higuchi Y; Hamaguchi M; Kaneko Y; Kirita Y; Taminishi S; Nishiji T; Taruno A; Fukui M; Arany Z; Matoba S
Nat Commun; 2023 Jul; 14(1):4084. PubMed ID: 37443159
[TBL] [Abstract][Full Text] [Related]
19. Hepatic autophagy fluctuates during the development of non-alcoholic fatty liver disease.
Ding H; Ge G; Tseng Y; Ma Y; Zhang J; Liu J
Ann Hepatol; 2020; 19(5):516-522. PubMed ID: 32553647
[TBL] [Abstract][Full Text] [Related]
20. Rhodiola activates macrophage migration inhibitory factor to alleviate non-alcoholic fatty liver disease.
Liu J; Li D; Dun Y; Li H; Ripley-Gonzalez JW; Zhang J; Qiu L; You B; Liu S
Life Sci; 2022 Nov; 308():120949. PubMed ID: 36096243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
